Vanberra Signal

DeepX Health

Curated by Signal

Developer of AI-based diagnostic devices for the identification of malignant melanoma

Overview

Developer of AI-based diagnostic devices for the identification of malignant melanoma. It offers Dermosight device that helps in the screening and early detection of skin cancer. The device has AI-algorithms that records spectral radiance images and also uses physiological properties and morphology parameters to diagnose the health of the skin.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Digital telehealth solution for providers

    Health TechnologyRichmond, United States
  • Developer of a medical device to treat post-traumatic stress disorder (PTSD)

    Health TechnologyNewberry, United States
  • Provider of an online content platform on supplements and vitamins

    Health TechnologyUnited States

About DeepX Health

What does DeepX Health do?

Developer of AI-based diagnostic devices for the identification of malignant melanoma.

Where is DeepX Health headquartered?

DeepX Health is headquartered in Washington, DC, United States.

When was DeepX Health founded?

DeepX Health was founded in 2019.

Which sector is DeepX Health in?

DeepX Health operates in Health Technology.

Who are DeepX Health's competitors?

Companies similar to DeepX Health include PreopMD, Evren, and Biotize.